Back to compounds

COMPOUND PROFILE / COMBINATIONS

GHRP-2 + CJC-1295.

Research draft

This entry combines GHRP-2 and a CJC-1295-labelled product.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Identity and evidence review notes

Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.

Component references are background only. No directly matched controlled combination result was established in this pass.

Overview

This entry combines GHRP-2 and a CJC-1295-labelled product.

CLASSIFICATIONCombinations
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCombination

Mechanism

It is proposed to combine ghrelin-receptor and GHRH signalling; DAC status changes exposure.

Human research

Human evidence for component hormone responses is not evidence of long-term benefit for the exact stack.

Preclinical & other research

GHRH-secretagogue experiments provide context, but different molecules cannot be substituted.

Safety & unknowns

Combined hormonal, glucose and exposure effects need clinical assessment.

Regulatory status

Resolve CJC sequence and DAC status before attaching evidence; no exact-stack authorisation was established.

Reported use & evidence

Research profile draft

The supplied GHRP-2 + CJC-1295 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds